HomeNewsDrug Discovery & Development

ANI Pharmaceuticals Introduces Prucalopride Tablets after FDA Approval

ANI Pharmaceuticals Introduces Prucalopride Tablets after FDA Approval

ANI Pharmaceuticals has announced that following final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the company has launched Prucalopride Tablets.

ANI’s Prucalopride Tablets is the generic version of the reference listed drug (RLD) Motegrity.

"We are delighted to build momentum early in 2025 with the approval of the first generic for Motegrity®, once again highlighting our superior R&D capabilities. The FDA has granted our Prucalopride Tablets a Competitive Generic Therapy (CGT) designation, with 180-day exclusivity. ANI continues to hold the second-highest number of CGT approvals in the U.S. Generics market,” stated Nikhil Lalwani, President and Chief Executive Officer of ANI.

US annual sales for Prucalopride Tablets total approximately USD 168.0 million, based on October 2024 moving annual total IQVIA data.

ANI Pharmaceuticals, is a diversified biopharmaceutical company committed to its mission of 'Serving Patients, Improving Lives' by developing, manufacturing, and commercializing innovative and high-quality therapeutics.

The company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its generics business, which leverages R&D expertise, operational excellence, and US based manufacturing; and its established brands business.

More news about: drug discovery & development | Published by Aishwarya | January - 03 - 2025

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members